NCT03510273View on ClinicalTrials.gov

Honduras Liger Thermocoagulator Study

NACompletedINTERVENTIONAL
Enrollment

320

Participants

Timeline

Start Date

May 4, 2018

Primary Completion Date

November 1, 2018

Study Completion Date

October 29, 2019

Conditions
Cervix CancerCervix Lesion
Interventions
DEVICE

Liger Medical Thermocoagulator

"Thermocoagulation treatment by Liger Medical device (US FDA 510K clearance received)"

Trial Locations (1)

98121

PATH, Seattle

All Listed Sponsors
collaborator

Ashonplafa

OTHER

collaborator

Ministry of Health, Honduras

OTHER_GOV

lead

PATH

OTHER

NCT03510273 - Honduras Liger Thermocoagulator Study | Biotech Hunter | Biotech Hunter